Pharmacogenetics of controlled ovarian hyperstimulation

Author： de Castro Francisco   Morón Francisco J   Montoro Luis   Real Luis M   Ruiz Agustín  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.6, 2005-09, pp. : 629-637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Controlled ovarian hyperstimulation pharmacogenetics: a simplified model to genetically dissect estrogen-related diseases

By Morón Francisco Jesús   Galán José Jorge   Ruiz Agustín  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 775-785

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers

By Morón Francisco Jesús   Ruiz Agustín  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1613-1618

Future Medicine

Access to resources Recommend Favorite

Pharmacotherapy of ovarian hyperstimulation syndrome

By Genazzani Andrea Riccardo   Monteleone Patrizia   Papini Francesca   Artini Paolo Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2527-2534

Informa Healthcare

Access to resources Recommend Favorite

Genetics of ovarian hyperstimulation syndrome

By Rizk Botros  

Reproductive BioMedicine Online, Vol. 19, Iss. 1, 2009-07 ,pp. : 14-27

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Modeling Follicle Stimulating Hormone Levels in Serum for Controlled Ovarian Hyperstimulation I: Comparing Gonadotropin Products

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 3, 2012-03 ,pp. : 435-443

Bentham Science Publishers

Access to resources Recommend Favorite